← Every applicant
Omnivium Pharms FDA Approvals
3 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| OLANZAPINENew drugJan 23, 2026POWDER, INTRAMUSCULAR |
| SODIUM BICARBONATENew drugJun 15, 2023SOLUTION, INTRAVENOUS |
| GLYCOPYRROLATENew drugNov 28, 2022INJECTABLE, INJECTION |